Knowledge (XXG)

Reversible inhibition of sperm under guidance

Source 📝

107:
humans. As India's population grew throughout the 1970s, Guha modified his heart pump design to create a water pump that could work off of differences in ionic charges between salt water and fresh water in water treatment facilities. This filtration system did not require electricity and could potentially help large groups of people have access to clean water. India, however, decided that the population problem would be better served by developing more effective contraception. So Guha again modified his design to work safely inside the body, specifically inside the male genitalia. The non-toxic polymer of RISUG also uses differences in the charges of the
295:
than there are for women, or they may fear the side effects, or it may conflict with their cultural or religious beliefs. However, the same study published that in the year 2000, an international survey found that 83% of men were willing to use a male contraceptive. Despite this, pharmaceutical companies are reluctant to lose market share of a thriving global market for female contraceptives and condoms which bring billions of dollars of revenue each year. Initially, RISUG attracted some interest from pharmaceutical companies. However, considering that RISUG is an inexpensive, one-time procedure, manufacturers retracted.
28: 320:
fertility. Smart RISUG is therefore a better choice for men who want to use RISUG as temporary birth control, since it does not require a second surgery to restore fertility. The addition of metal ions also increases the effectiveness of the spermicide. The low frequency electromagnetic field disintegrates the sperm cell membrane in the head region. This in turn causes both
287:, the average time taken for a drug to go from concept to market is 10 to 15 years, whereas, it has been over four decades since Guha published his original paper on RISUG. RISUG aims to provide males with years-long fertility control, thereby overcoming compliance problems and avoiding ongoing costs associated with condoms and the female 279:
had successfully completed clinical trials of the world's first injectable male contraceptive, which was then sent to the Drug Controller General of India (DCGI) for regulatory approval. The trials were over, including extended, phase III clinical trials, for which 303 candidates were recruited with
234:
of clinical trials on the basis of presence of styrene and maleic anhydride in the formulation. In response, Guha argued that substances can be individually toxic in nature but harmless as compounds like pure chlorine, which can melt human flesh on its own, but, when combined with sodium, it becomes
319:
With the presence of iron particles, the polymer has lower protein binding and therefore prevents agglomeration. The copper particles in the compound allow the polymer to conduct heat. When an external microwave applies heat to the polymer, it can liquify the polymer again to be excreted to restore
303:
Smart RISUG is a newer version of the male contraception that was published in 2009. The polymer adds iron oxide and copper particles to the original compound, giving it magnetic properties and the name "Smart RISUG". After injection the exact location of the polymer inside the vas deferens can be
294:
Pharmaceutical companies have expressed little interest in RISUG. One obstacle facing marketing of the product is that men generally perceive contraception as a woman's issue. Men may choose not to use alternative methods of contraception because there are fewer options for birth control for them
106:
developed RISUG after years of developing other inventions. He originally wanted to create an artificial heart that could pump blood using a strong electrical pulse. Using the 13-chamber model of a cockroach heart, he designed a softer pumping mechanism that would theoretically be safe to use in
266:
and Indian researchers say that the studies were not done according to recent international standards. Due to the lack of any evidence for adverse effects, trials were restarted in 2011. Guha says concerns over the safety and efficacy of the drug have mainly come from the NIH and WHO.
188:
for every 40 g of copolymer and a dose rate of 30 to 40 rad/s. Dr Pradeep K. Jha, a senior scientist, worked on the effects of gamma dose rate and total dose interrelation on molecular designing and biological function of polymer. The source of irradiation is
312:. The polymer location can also be externally controlled using a pulsed magnetic field. With this magnetic field, the polymer can change location inside the body to maximize sterility or can be removed to restore fertility. The polymer has 559:
Jha, Pradeep K.; Jha, Rakhi; Gupta, B.L.; Guha, Sujoy K. (May 2010). "Effect of γ-dose rate and total dose interrelation on the polymeric hydrogel: A novel injectable male contraceptive".
331:
The safety of Smart RISUG is uncertain and requires additional research. The spermicidal properties of the compound should not have negative effects on the lining of the vas deferens.
356: 693: 671: 983: 1410: 1131: 1292: 1164: 479: 58: 432: 917:
Sharma, RadheyShyam; Mathur, AjitKumar; Singh, Rajeev; Das, HemChandra; Singh, GulshanJeet; Toor, DevinderPal Singh; Guha, SujoyKumar (2019).
1184: 518: 1329: 1037: 335:
rats used to develop the new polymer did not have any adverse symptoms. The original compound had been tested for over 25 years in rats.
1007: 976: 595: 316:
that allows it to stretch and elongate to better line the vas deferens. The iron oxide component is necessary to prevent agglomeration.
366: 239:
and the clinical trials did not resume by 1996, he went to the Supreme court and the next round of clinical trials resumed afterwards.
276: 259: 236: 1141: 919:"Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience" 1415: 1405: 1126: 872: 714: 1420: 1027: 313: 157:, and the vasa deferentia are injected with a polymer gel (rather than being cut and cauterized). In a matter of minutes, the 1156: 969: 361: 1146: 663: 87:, who were unable to bring the product to market over the next decade. In 2023, the patent for Vasalgel was acquired by 231: 73: 418: 1351: 1316: 534: 309: 199:
The effect the chemical has on sperm is not completely understood. Originally, researchers thought it lowered the
1229: 1174: 263: 133:, which has branded it as "Vasalgel". Vasalgel, which has a slightly different formulation than RISUG, underwent 1082: 165: 46: 860: 1244: 455: 1324: 1116: 1107: 1071: 243: 130: 1206: 1169: 1063: 122: 88: 440: 483: 210:
mosaic. Within an hour after placement the differential charge from the gel will rupture the sperm's
1234: 568: 158: 92: 1359: 1334: 1136: 1048: 247: 145:
RISUG works by an injection into the vas deferens, the vessel through which the sperm moves before
126: 84: 1384: 1339: 1259: 1012: 288: 173: 54: 1364: 950: 905: 829: 811: 790:"Smart RISUG: A potential new contraceptive and its magnetic field-mediated sperm interaction" 770: 514: 508: 235:
sodium chloride – the basic salt that people consume in their diets. When it did not persuade
593: 940: 930: 895: 819: 801: 760: 750: 576: 876: 864: 698: 637: 599: 284: 223: 207: 193: 572: 1264: 1090: 945: 918: 900: 883: 824: 789: 765: 738: 255: 134: 869: 737:
Khilwani, Barkha; Badar, Ayesha; Ansari, Abdul S.; Lohiya, Nirmal K. (December 2020).
580: 31:
Diagram showing the site of injection of the product Vasalgel, a vasectomy alternative
1399: 1274: 1219: 1022: 992: 325: 211: 103: 66: 76:
clinical trials were underway in India, and were slowed by insufficient volunteers.
1269: 1224: 1192: 1052: 116: 611: 1297: 1284: 214:
as it passes through the vas, deactivating it before it can exit from the body.
177: 146: 125:
rights to RISUG in the United States were acquired between 2010 and 2012 by the
882:
Lohiya, N.K.; Alam, I.; Hussain, M.; Khan, S.R.; Ansari, A.S. (November 2014).
27: 1254: 1057: 851: 755: 185: 169: 935: 815: 393: 1096: 1067: 190: 162: 150: 72:
RISUG has been patented in India, China, Bangladesh, and the United States.
954: 909: 833: 774: 638:"The Professor Who Had to Spend Half His Life to Make the Drug India Needs" 1017: 227: 961: 321: 181: 161:
coats the walls of the vasa with a clear gel made of 60 mg of the
154: 153:
in that a local anesthetic is administered, an incision is made in the
43: 806: 1214: 332: 17: 206:
Guha theorizes that the polymer surface has a negative and positive
857: 305: 251: 112: 108: 62: 26: 965: 739:"RISUG® as a male contraceptive: journey from bench to bedside" 91:, which plans to bring the technology to market under the name 357:"Poor response from male volunteers hits RISUG clinical trial" 328:
enzymes to leak out of the sperm, making the sperm infertile.
662:
Indian Ministry of Health & Family Welfare (2002-10-11).
137:
in the United States, but reversibility proved unsuccessful.
694:"India closer to world's first male contraceptive injection" 262:
has reviewed and approved the toxicology data three times,
200: 79:
Beginning in 2011, a contraceptive product based on RISUG,
230:
testing in clinical trials had been questioned after
884:"RISUG: An intravasal injectable male contraceptive" 788:
Jha, Rakhi K; Jha, Pradeep K; Guha, Sujoy K (2009).
419:"'Plan A' Offers a New Option in Male Birth Control" 394:"The Revolutionary New Birth Control Method for Men" 1377: 1348: 1313: 1306: 1283: 1243: 1205: 1183: 1155: 1115: 1106: 1081: 1036: 1000: 280:97.3% success rate and no reported side effects. 350: 348: 246:aborted the clinical trials due to reports of 977: 203:of the environment enough to kill the sperm. 36:Reversible inhibition of sperm under guidance 8: 715:"A New Kind of Male Birth Control Is Coming" 732: 730: 728: 1310: 1112: 1018:Preventing sexually-transmitted infections 984: 970: 962: 632: 630: 628: 535:"Expanding Options for Male Contraception" 510:The Oxford Handbook of Reproductive Ethics 944: 934: 899: 823: 805: 764: 754: 502: 500: 83:, was under development in the US by the 42:), formerly referred to as the synthetic 513:. Oxford University Press. p. 336. 482:. Parsemusfoundation.org. Archived from 539:Planned Parenthood Advocates of Arizona 387: 385: 383: 344: 888:The Indian Journal of Medical Research 1411:Experimental methods of birth control 794:International Journal of Nanomedicine 7: 1023:Over-the-counter oral contraceptives 614:. MaleContraceptives.org. 2011-07-27 1008:Comparison of birth control methods 1385:Male contraceptives in development 923:Indian Journal of Medical Research 692:Kaul, Rhythma (19 November 2019). 25: 713:Altstedter, Ari (29 March 2017). 581:10.1016/j.radphyschem.2009.11.010 439:. April 14, 2008. Archived from 53:), is the development name of a 1028:Oral contraceptive formulations 674:from the original on 2023-06-04 561:Radiation Physics and Chemistry 1: 417:Hobbins, Katie (2023-08-22). 355:Jyoti, Archana (2011-01-03). 291:, which must be taken daily. 743:Basic and Clinical Andrology 456:"'Honey, It's Your Turn...'" 454:Beck, Melinda (2011-06-14). 433:"An Indian artificial heart" 392:Gifford, Bill (2011-04-26). 176:. The copolymer is made by 1335:Fertility awareness methods 365:. New Delhi. Archived from 304:measured and visualized by 258:participants. Although the 184:with a dose of 0.2 to 0.24 131:not-for-profit organization 1437: 310:magnetic resonance imaging 271:Availability and marketing 244:India's Ministry of Health 1330:Calendar (rhythm) methods 756:10.1186/s12610-020-0099-1 936:10.4103/ijmr.IJMR_635_18 507:Francis, Leslie (2017). 254:and scrotal swelling in 166:styrene/maleic anhydride 115:as it flows through the 47:styrene maleic anhydride 1416:Contraception for males 1406:Male genital procedures 1245:Emergency Contraception 870:ICMR 2004 Annual Report 598:March 17, 2005, at the 460:The Wall Street Journal 314:magnetoelastic behavior 57:injection developed at 1421:Biological engineering 1165:Multi-month injections 1108:Hormonal contraception 1072:Levonorgestrel implant 1038:Long-acting reversible 275:By November 2019, the 149:. RISUG is similar to 32: 1293:Vaginal pH modulation 1270:Low-dose mifepristone 1170:Progestogen-only pill 1064:Contraceptive implant 852:U.S. patent 5,488,075 480:"Parsemus Foundation" 421:. www.mddionline.com. 123:Intellectual property 30: 1325:Breastfeeding method 1235:Contraceptive sponge 1119:estrogen–progestogen 1068:Etonogestrel implant 894:(Suppl 1): S63–S72. 664:"PIB Press Releases" 222:The thoroughness of 1360:Non-penetrative sex 1352:vaginal intercourse 1317:vaginal intercourse 1137:Contraceptive patch 1132:Extended cycle Pill 1049:Intrauterine device 1013:Male contraceptives 573:2010RaPC...79..663J 127:Parsemus Foundation 85:Parsemus Foundation 65:by the team of Dr. 1260:Ulipristal acetate 1248:(Post-intercourse) 1142:Monthly injections 875:2012-04-15 at the 863:2013-03-08 at the 668:archive.pib.gov.in 289:birth control pill 174:dimethyl sulfoxide 89:NEXT Life Sciences 55:male contraceptive 33: 1393: 1392: 1373: 1372: 1201: 1200: 807:10.2147/ijn.s4818 520:978-0-19-998187-8 443:on July 22, 2009. 242:In October 2002, 16:(Redirected from 1428: 1311: 1157:Progestogen-only 1113: 986: 979: 972: 963: 958: 948: 938: 913: 903: 854: 838: 837: 827: 809: 785: 779: 778: 768: 758: 734: 723: 722: 710: 704: 703: 689: 683: 682: 680: 679: 659: 653: 652: 650: 649: 634: 623: 622: 620: 619: 608: 602: 591: 585: 584: 556: 550: 549: 547: 546: 531: 525: 524: 504: 495: 494: 492: 491: 476: 470: 469: 467: 466: 451: 445: 444: 429: 423: 422: 414: 408: 407: 405: 404: 389: 378: 377: 375: 374: 352: 21: 1436: 1435: 1431: 1430: 1429: 1427: 1426: 1425: 1396: 1395: 1394: 1389: 1369: 1350: 1344: 1315: 1302: 1279: 1247: 1239: 1220:Internal condom 1215:External condom 1207:Barrier Methods 1197: 1179: 1151: 1118: 1102: 1077: 1039: 1032: 996: 990: 916: 881: 877:Wayback Machine 865:Wayback Machine 850: 847: 842: 841: 787: 786: 782: 736: 735: 726: 712: 711: 707: 699:Hindustan Times 691: 690: 686: 677: 675: 661: 660: 656: 647: 645: 636: 635: 626: 617: 615: 610: 609: 605: 600:Wayback Machine 592: 588: 558: 557: 553: 544: 542: 533: 532: 528: 521: 506: 505: 498: 489: 487: 478: 477: 473: 464: 462: 453: 452: 448: 431: 430: 426: 416: 415: 411: 402: 400: 391: 390: 381: 372: 370: 354: 353: 346: 341: 301: 285:developed world 273: 256:phase III trial 224:carcinogenicity 220: 208:electric charge 194:gamma radiation 172:of the solvent 168:(SMA) with 120 143: 111:to rupture the 101: 23: 22: 15: 12: 11: 5: 1434: 1432: 1424: 1423: 1418: 1413: 1408: 1398: 1397: 1391: 1390: 1388: 1387: 1381: 1379: 1375: 1374: 1371: 1370: 1368: 1367: 1362: 1356: 1354: 1346: 1345: 1343: 1342: 1337: 1332: 1327: 1321: 1319: 1308: 1304: 1303: 1301: 1300: 1295: 1289: 1287: 1281: 1280: 1278: 1277: 1272: 1267: 1265:Levonorgestrel 1262: 1257: 1251: 1249: 1241: 1240: 1238: 1237: 1232: 1227: 1222: 1217: 1211: 1209: 1203: 1202: 1199: 1198: 1196: 1195: 1189: 1187: 1181: 1180: 1178: 1177: 1172: 1167: 1161: 1159: 1153: 1152: 1150: 1149: 1144: 1139: 1134: 1129: 1123: 1121: 1110: 1104: 1103: 1101: 1100: 1094: 1091:Tubal ligation 1087: 1085: 1079: 1078: 1076: 1075: 1061: 1055: 1045: 1043: 1034: 1033: 1031: 1030: 1025: 1020: 1015: 1010: 1004: 1002: 1001:Related topics 998: 997: 991: 989: 988: 981: 974: 966: 960: 959: 914: 879: 867: 855: 846: 845:External links 843: 840: 839: 780: 724: 705: 684: 654: 624: 603: 586: 567:(5): 663–671. 551: 526: 519: 496: 471: 446: 424: 409: 379: 343: 342: 340: 337: 300: 297: 272: 269: 219: 216: 142: 139: 100: 97: 93:Plan A for Men 24: 14: 13: 10: 9: 6: 4: 3: 2: 1433: 1422: 1419: 1417: 1414: 1412: 1409: 1407: 1404: 1403: 1401: 1386: 1383: 1382: 1380: 1376: 1366: 1363: 1361: 1358: 1357: 1355: 1353: 1347: 1341: 1338: 1336: 1333: 1331: 1328: 1326: 1323: 1322: 1320: 1318: 1312: 1309: 1305: 1299: 1296: 1294: 1291: 1290: 1288: 1286: 1282: 1276: 1275:Yuzpe regimen 1273: 1271: 1268: 1266: 1263: 1261: 1258: 1256: 1253: 1252: 1250: 1246: 1242: 1236: 1233: 1231: 1228: 1226: 1223: 1221: 1218: 1216: 1213: 1212: 1210: 1208: 1204: 1194: 1191: 1190: 1188: 1186: 1182: 1176: 1173: 1171: 1168: 1166: 1163: 1162: 1160: 1158: 1154: 1148: 1145: 1143: 1140: 1138: 1135: 1133: 1130: 1128: 1125: 1124: 1122: 1120: 1114: 1111: 1109: 1105: 1098: 1095: 1092: 1089: 1088: 1086: 1084: 1083:Sterilization 1080: 1073: 1069: 1065: 1062: 1059: 1056: 1054: 1050: 1047: 1046: 1044: 1041: 1040:contraception 1035: 1029: 1026: 1024: 1021: 1019: 1016: 1014: 1011: 1009: 1006: 1005: 1003: 999: 994: 993:Birth control 987: 982: 980: 975: 973: 968: 967: 964: 956: 952: 947: 942: 937: 932: 928: 924: 920: 915: 911: 907: 902: 897: 893: 889: 885: 880: 878: 874: 871: 868: 866: 862: 859: 856: 853: 849: 848: 844: 835: 831: 826: 821: 817: 813: 808: 803: 799: 795: 791: 784: 781: 776: 772: 767: 762: 757: 752: 748: 744: 740: 733: 731: 729: 725: 720: 716: 709: 706: 701: 700: 695: 688: 685: 673: 669: 665: 658: 655: 643: 639: 633: 631: 629: 625: 613: 607: 604: 601: 597: 594: 590: 587: 582: 578: 574: 570: 566: 562: 555: 552: 540: 536: 530: 527: 522: 516: 512: 511: 503: 501: 497: 486:on 2012-10-14 485: 481: 475: 472: 461: 457: 450: 447: 442: 438: 437:The Telegraph 434: 428: 425: 420: 413: 410: 399: 395: 388: 386: 384: 380: 369:on 2011-06-12 368: 364: 363: 358: 351: 349: 345: 338: 336: 334: 329: 327: 326:hyaluronidase 323: 317: 315: 311: 307: 298: 296: 292: 290: 286: 281: 278: 270: 268: 265: 261: 257: 253: 249: 245: 240: 238: 233: 229: 225: 217: 215: 213: 212:cell membrane 209: 204: 202: 197: 195: 192: 187: 183: 179: 175: 171: 167: 164: 160: 156: 152: 148: 140: 138: 136: 135:animal trials 132: 128: 124: 120: 118: 114: 110: 105: 104:Sujoy K. Guha 98: 96: 94: 90: 86: 82: 77: 75: 70: 68: 67:Sujoy K. Guha 64: 60: 59:IIT Kharagpur 56: 52: 48: 45: 41: 37: 29: 19: 1378:Experimental 1225:Cervical cap 1193:Ormeloxifene 1175:Vaginal ring 1147:Vaginal ring 1053:Hormonal IUD 929:(1): 81–86. 926: 922: 891: 887: 858:ICMR Website 797: 793: 783: 746: 742: 718: 708: 697: 687: 676:. Retrieved 667: 657: 646:. Retrieved 644:. 2016-11-17 641: 616:. Retrieved 606: 589: 564: 560: 554: 543:. Retrieved 541:. 2011-08-08 538: 529: 509: 488:. Retrieved 484:the original 474: 463:. Retrieved 459: 449: 441:the original 436: 427: 412: 401:. Retrieved 397: 371:. Retrieved 367:the original 360: 330: 318: 302: 293: 282: 274: 241: 221: 205: 198: 144: 121: 117:vas deferens 102: 80: 78: 71: 50: 39: 35: 34: 1298:Nonoxynol-9 1285:Spermicides 362:The Pioneer 299:Smart RISUG 180:of the two 178:irradiation 147:ejaculation 99:Development 1400:Categories 1365:Abstinence 1340:Withdrawal 1307:Behavioral 1255:Copper IUD 1058:Copper IUD 678:2023-10-31 648:2020-10-19 618:2013-10-30 545:2012-03-28 490:2012-10-13 465:2012-10-13 403:2020-10-19 373:2011-06-08 339:References 141:Mechanisms 1314:Including 1230:Diaphragm 1127:Oral pill 1097:Vasectomy 816:1176-9114 800:: 55–64. 719:Bloomberg 191:cobalt-60 163:copolymer 159:injection 151:vasectomy 74:Phase III 1349:Avoiding 1117:Combined 1093:(female) 955:31571633 910:25673546 873:Archived 861:Archived 834:19421370 775:32082579 749:(1): 2. 672:Archived 642:The Wire 596:Archived 228:toxicity 182:monomers 81:Vasalgel 995:methods 946:6798614 901:4345756 825:2720737 766:7017607 612:"RISUG" 569:Bibcode 322:acrosin 283:In the 248:albumin 232:phase I 186:megarad 155:scrotum 44:polymer 1099:(male) 1042:(LARC) 953:  943:  908:  898:  832:  822:  814:  773:  763:  517:  333:Albino 218:Safety 1185:SERMs 398:Wired 306:X-ray 252:urine 113:sperm 109:semen 63:India 40:RISUG 18:RISUG 951:PMID 906:PMID 830:PMID 812:ISSN 771:PMID 515:ISBN 324:and 308:and 277:ICMR 260:ICMR 237:ICMR 226:and 129:, a 941:PMC 931:doi 927:150 896:PMC 892:140 820:PMC 802:doi 761:PMC 751:doi 577:doi 264:WHO 250:in 61:in 51:SMA 1402:: 1070:, 949:. 939:. 925:. 921:. 904:. 890:. 886:. 828:. 818:. 810:. 796:. 792:. 769:. 759:. 747:30 745:. 741:. 727:^ 717:. 696:. 670:. 666:. 640:. 627:^ 575:. 565:79 563:. 537:. 499:^ 458:. 435:. 396:. 382:^ 359:. 347:^ 201:pH 196:. 170:μL 119:. 95:. 69:. 1074:) 1066:( 1060:) 1051:( 985:e 978:t 971:v 957:. 933:: 912:. 836:. 804:: 798:4 777:. 753:: 721:. 702:. 681:. 651:. 621:. 583:. 579:: 571:: 548:. 523:. 493:. 468:. 406:. 376:. 49:( 38:( 20:)

Index

RISUG

polymer
styrene maleic anhydride
male contraceptive
IIT Kharagpur
India
Sujoy K. Guha
Phase III
Parsemus Foundation
NEXT Life Sciences
Plan A for Men
Sujoy K. Guha
semen
sperm
vas deferens
Intellectual property
Parsemus Foundation
not-for-profit organization
animal trials
ejaculation
vasectomy
scrotum
injection
copolymer
styrene/maleic anhydride
μL
dimethyl sulfoxide
irradiation
monomers

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.